Table 5.

Risk of MM for selected conditions by latency in white and black US male veterans

	Follow-up 2 to 4 y			Follow-up 5 to 9 y			Follow-up 10 or more y
	N	RR*	95% CI	N	RR*	95% CI	N	RR*	95% CI
Total autoimmune	111	1.31	1.06-1.61	99	1.14	0.91-1.41	152	1.07	0.90-1.26
Autoantibodies detectable	84	1.32	1.04-1.68	77	1.21	0.95-1.55	123	1.20	1.00-1.44
Systemic involvement	27	1.20	0.80-1.80	34	1.43	1.00-2.06	51	1.20	0.90-1.61
Polymyositis/dermatomyositis	3	—	—	2	—	—	1	—	—
Systemic sclerosis	1	—	—	4	—	—	1	—	—
Organ involvement	58	1.38	1.03-1.85	46	1.03	0.75-1.43	79	1.26	1.01-1.57
Autoimmune hemolytic anemia	4	—	—	4	—	—	3	—	—
Pernicious anemia	9	2.00	0.95-4.21	6	2.14	1.02-4.51	12	2.25	1.28-3.98
Autoantibodies not detectable	33	1.31	0.90-1.91	30	1.02	0.69-1.52	44	0.90	0.67-1.21
Ankylosing spondylitis	5	2.04	0.85-4.92	8	2.17	0.97-4.84	12	2.46	1.46-4.17
Total infections	386	1.40	1.22-1.60	311	1.26	1.10-1.45	528	1.24	1.11-1.37
Influenza	8	1.68	0.79-3.51	4	—	—	18	1.32	0.83-2.10
Pneumonia	206	1.82	1.53-2.16	148	1.50	1.25-1.80	242	1.42	1.23-1.63
Hepatitis	4	—	—	10	2.61	1.35-5.05	15	1.66	0.99-2.76
Meningitis	6	3.45	1.29-9.22	3	—	—	8	1.84	0.87-3.86
Septicemia	30	1.45	0.93-2.26	19	1.12	0.69-1.81	58	1.57	1.17-2.09
Herpes zoster	8	1.30	0.58-2.90	15	2.54	1.47-4.40	20	2.04	1.30-3.21
Poliomyelitis	2	—	—	1	—	—	6	3.69	1.75-7.75
Total inflammatory disorders	358	1.18	0.99-1.40	317	1.21	1.02-1.44	494	1.01	0.89-1.16
Glomerulonephritis	28	1.89	1.17-3.06	28	2.22	1.46-3.37	24	0.72	0.43-1.19
Nephrotic syndrome	15	3.91	2.03-7.55	18	3.15	1.57-6.33	11	0.81	0.30-2.16
Osteoarthritis	216	1.21	1.03-1.43	201	1.32	1.1.13-1.55	325	1.27	1.12-1.44
Total allergies	69	1.22	0.93-1.60	68	1.18	0.91-1.52	120	1.00	0.83-1.21
Allergic rhinitis	5	1.63	0.61-4.34	2	—	—	13	1.59	0.92-2.74

— indicates RR and CI not calculated due to small numbers.

^*RR adjusted for number of visits, race, latency, attained age, and calendar time.